Quince Therapeutics’ (QNCX) “Buy” Rating Reaffirmed at D. Boral Capital
D. Boral Capital reissued their buy rating on shares of Quince Therapeutics (NASDAQ:QNCX – Free Report) in a report issued on Wednesday,Benzinga reports. D. Boral Capital currently has a $12.00 price ...
Insider Monkey1d
Hedge Fund Investor Letters Q4 2024
That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet… And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars ...
BBC4d
Hedge End
Largely cloudy, if not overcast through the overnight period. Largely dry but one or two spots of drizzle cloud develop locally. Thursday Tomorrow will generally see a mixture of both cloudy and ...
InStyle6d
I'm Buying These 15 Early Spring Staples That Look Way More Expensive Than They Are
Including cashmere tees, linen pants, and more from just $30.